Lonza wins $7m US NIH stem cell contract
Lonza has won a second US NIH contract to manufacture stem cells for medical research.
Lonza has won a second US NIH contract to manufacture stem cells for medical research.
CiToxLAB says strong revenue growth in 2012 was due to a new global status following its acquisition of Lab Research.